Investment type
Equity - Shares of Stock
Class
Ordinary Shares, nominal value of GBP0.05 per share
Latest Disclosed Ownership
10.7M shares
Security Ownership
7.6%

Lombard Odier Asset Management (USA) Corp ownership in Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share

2025-02-11 - Lombard Odier Asset Management (USA) Corp has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10.7M shares of Silence Therapeutics Plc Ordinary Shares, nominal value of GBP0.05 per share. This represents 7.6% percent ownership of the company.